Security key
00510M203
Acurx Pharmaceuticals, Inc. - Common Stock, Par Value $0.01 per share (ACXP)
CUSIP: 00510M203
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, Par Value $0.01 per share
- Total 13F shares
- 55,793
- Total 13F value
- $244,384
- Share change
- +55,626
- SEC-reported price per share
- $4.29
- Number of holders
- 16
- Value change
- +$231,208
- Number of buys
- 15
- Number of sells
- 1
- Shares outstanding
- 12,886,256
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
16
Top holders
10
ACXP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Acurx Pharmaceuticals, Inc. SEC filings
Acurx Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00510M203
Recent filing periods:
Ownership snapshot
Top reported holders of ACXP - Acurx Pharmaceuticals, Inc. - Common Stock, Par Value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
7/15
Latest evidence
30 Jun 2025
13F
13D/G
Lead comparable stake: 5%
8 rows are not safely comparable across share classes.
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5%.
7 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
5%
HRT FINANCIAL LP
0.81%
RAYMOND JAMES FINANCIAL INC
0.01%
IFP Advisors, Inc
0%
Cornerstone Planning Group LLC
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
13D/G
Company
|
5%
from 13D/G
|
$550,918
1,078,540 shares
|
— | 30 Jun 2025 |
| HRT FINANCIAL LP |
13F
Company
|
0.81%
|
$17,000
13,459 shares
|
— | 30 Jun 2025 |
| RAYMOND JAMES FINANCIAL INC |
13F
Company
|
0.01%
|
$114
89 shares
|
— | 30 Jun 2025 |
| IFP Advisors, Inc |
13F
Company
|
0%
|
$52
41 shares
|
— | 30 Jun 2025 |
| Cornerstone Planning Group LLC |
13F
Company
|
0%
|
$850
167 shares
|
— | 30 Jun 2025 |
| Darwin Wealth Management, LLC |
13F
Company
|
0%
|
$1
1 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
16
Shares
55,793
Rows available
16
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
1
Q3 2025 holders
16
Holder diff
15
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend